JP Morgan Initiates Coverage On Carpenter Tech with Neutral Rating, Announces Price Target of $49

JP Morgan analyst Michael Glick initiates coverage on Carpenter Tech (NYSE: CRS) with a Neutral rating and announces Price Target of $49.JP Morgan analyst Michael Glick initiates coverage on Carpenter Tech (NYSE:CRS) with a Neutral rating and announces Pri

byBenzinga Newsdesk

June 16, 2021

1 minute read

JP Morgan analyst Michael Glick initiates coverage on Carpenter Tech (NYSE:CRS) with a Neutral rating and announces Price Target of $49.JP Morgan analyst Michael Glick initiates coverage on Carpenter Tech (NYSE:CRS) with a Neutral rating and announces Price Target of $49.

Tenax Thearpeutics Reports Was Granted US Patent For Subcutaneous Use Of Levosimendan

By Benzinga Newsdesk

Today, 2:44 AM

Provides Broad Coverage for Use of TNX-102 for the Treatment of Human Subjects with Any Health Condition Patent Term to 2039, Exclusive of Any Possible Extensions MORRISVILLE, N.C., Jan. 12, 2022

TENX

Cowen & Co. Initiates Coverage On Agilon Health with Outperform Rating, Announces Price Target of $44

By Benzinga Newsdesk

Today, 2:44 AM

Cowen & Co. analyst Gary Taylor initiates coverage on Agilon Health (NYSE:AGL) with a Outperform rating and announces Price Target of $44.

AGL

Viatris Q4 EPS $0.83 Up From $(0.22) YoY, Sales $3.88B Miss $3.97B Estimate

By Benzinga Newsdesk

Today, 2:44 AM

Viatris (NASDAQ:VTRS) reported quarterly earnings of $0.83 per share. This is a 477.27 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $3.88

VTRS

Reported Late Tuesday March 14, Accelerate Diagnostics Announces Departure Of CFOSteve Reichling And Appointment Of David Patience As Replacement Effective April 1, 2023

By Happy Mohamed

Today, 2:44 AM

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be stepping down as Chief Financial Officer (CFO),

AXDX

JP Morgan Initiates Coverage On Carpenter Tech with Neutral Rating, Announces Price Target of $49

Related Posts

Tenax Thearpeutics Reports Was Granted US Patent For Subcutaneous Use Of Levosimendan

Cowen & Co. Initiates Coverage On Agilon Health with Outperform Rating, Announces Price Target of $44

Viatris Q4 EPS $0.83 Up From $(0.22) YoY, Sales $3.88B Miss $3.97B Estimate

Reported Late Tuesday March 14, Accelerate Diagnostics Announces Departure Of CFOSteve Reichling And Appointment Of David Patience As Replacement Effective April 1, 2023